Developer of a platform for building clinical AI agents. Developer of a platform for building clinical AI agents. The platform enables healthcare organizations to create patient-facing agents for care delivery. It facilitates clinician-led development, simulation-validated evaluations, and real-time monitoring. The cognitive architecture is designed for healthcare, emphasizing control, reliability, and observability. The company operates in the High Tech > Chatbots sector. Founded in 2023 and headquartered in New York, United States and has raised $17.3 million in Series A funding. Key investors include Madrona, Optum Ventures, General Catalyst, GSV Ventures, ACOF.
← All startups
Amigo
Series ADeveloper of a platform for building clinical AI agents. Developer of a platform for building clinical AI agents. The platform enables healthcare organizations to create patient-facing agents for care delivery. It facilitates clinician-led development, simulation-validated evaluations, and real-time monitoring. The cognitive architecture is designed for healthcare, emphasizing control, reliability, and…
About
Business model
Chatbots > Chatbot Development > Conversational AI Development
Institutional investors
MadronaOptum VenturesGeneral CatalystGSV VenturesACOF
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ See who's investing in High Tech — full fund directory with check size and geography.